{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:50Z","timestamp":1791704810207,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019558","name":"Qingdao Key Health Discipline Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-19-37"],"award-info":[{"award-number":["320.6750.2022-19-37"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103032","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:51:12Z","timestamp":1789764672000},"page":"103032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Siglec\u201315 promotes a feed-forward loop between TNBC cells and macrophages via the NF-\u03baB\/DcR3\/CCL18\/STAT3 axis"],"prefix":"10.1016","volume":"73","author":[{"given":"Sizhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103032_bib0001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2026.103032_bib0002","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103032_bib0003","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1002\/cncr.27581","article-title":"Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network","volume":"118","author":"Lin","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2026.103032_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.tranon.2026.103032_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2026.103032_bib0006","article-title":"The promising role of tumor-associated macrophages in the treatment of cancer","volume":"73","author":"Wang","year":"2024","journal-title":"Drug. Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.tranon.2026.103032_bib0007","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102614","article-title":"Novel targets for immune-checkpoint inhibition in cancer","volume":"120","author":"Borgeaud","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tranon.2026.103032_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2012.11.036","article-title":"Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice","volume":"53","author":"Hiruma","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.tranon.2026.103032_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2011.05.015","article-title":"Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation","volume":"409","author":"Hiruma","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2026.103032_bib0011","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40364-022-00369-1","article-title":"The intriguing roles of Siglec family members in the tumor microenvironment","volume":"10","author":"Jiang","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tranon.2026.103032_bib0013","article-title":"Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis","volume":"121","author":"Wang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tranon.2026.103032_bib0014","article-title":"Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasisA","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-024-01325-4","article-title":"Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors","volume":"16","author":"Lin","year":"2024","journal-title":"Genom. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0016","first-page":"515","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science (1979)"},{"key":"10.1016\/j.tranon.2026.103032_bib0017","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/thno.87962","article-title":"Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.103032_bib0018","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13277-015-3825-0","article-title":"CCL18 promotes the invasion and migration of gastric cancer cells via ERK1\/2\/NF-\u03bab signaling pathway","volume":"37","author":"Hou","year":"2016","journal-title":"Tumour. Biol. J. Int. Soc. Oncodevelopm. Biol. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0019","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12885-020-07073-z","article-title":"CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2\/STAT3 signaling pathway","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2026.103032_bib0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo.2014.2794","article-title":"CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma","volume":"46","author":"Meng","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2026.103032_bib0021","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mc.22419","article-title":"CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway","volume":"55","author":"Wang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.tranon.2026.103032_bib0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2021.03.005","article-title":"The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment","volume":"60","author":"Cardoso","year":"2021","journal-title":"Cytokine Grow. Fact. Rev."},{"key":"10.1016\/j.tranon.2026.103032_bib0023","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.21873\/anticanres.12676","article-title":"CC-Chemokine Ligand 18 is an independent prognostic marker in lymph node-positive non-small cell lung cancer","volume":"38","author":"Schmid","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tranon.2026.103032_bib0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2017.02.004","article-title":"Decellularized human colorectal cancer matrices polarize macrophages towards an anti-inflammatory phenotype promoting cancer cell invasion via CCL18","volume":"124","author":"Pinto","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.tranon.2026.103032_bib0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2004.05.031","article-title":"Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer","volume":"127","author":"Leung","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tranon.2026.103032_bib0026","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0027","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-17-2158","article-title":"Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and cancer mesenchymal cells through a complex chemokine network","volume":"79","author":"Valeta-Magara","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.103032_bib0028","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/carcin\/bgy136","article-title":"Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells","volume":"39","author":"Hao","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tranon.2026.103032_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tranon.2018.10.004","article-title":"Co-expression of VEGF and IL-6 Family cytokines is associated with decreased survival in HER2 negative breast cancer patients: subtype-specific IL-6 Family cytokine-mediated VEGF secretion","volume":"12","author":"Tawara","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2026.103032_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/cas.16068","article-title":"IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18\/STAT3 pathway","volume":"115","author":"Zhou","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0031","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10238-022-00906-0","article-title":"DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18\/STAT3 signaling pathway","volume":"23","author":"Luo","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0032","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1200\/JCO.2009.27.2146","article-title":"Immune regulation of cancer","volume":"28","author":"Disis","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103032_bib0033","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03bab signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103032_bib0034","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2026.103032_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/or_00000690","article-title":"Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma","volume":"23","author":"Xie","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2026.103032_bib0036","first-page":"1624","article-title":"Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice","volume":"40","author":"Yoshida","year":"1999","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0037","first-page":"8441","article-title":"Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, akt-, and NF-kappa B-dependent pathway","volume":"181","author":"Chen","year":"2008","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"10.1016\/j.tranon.2026.103032_bib0038","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/carcin\/bgp135","article-title":"Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion","volume":"30","author":"Ho","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tranon.2026.103032_bib0039","first-page":"2464","article-title":"Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages","volume":"188","author":"Tai","year":"2012","journal-title":"J. Immunol. Baltim. Md. 1950"},{"key":"10.1016\/j.tranon.2026.103032_bib0040","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1182\/blood-2007-12-130609","article-title":"Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3","volume":"111","author":"Chang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.103032_bib0041","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/thy.2012.0261","article-title":"Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion","volume":"23","author":"Chang","year":"2013","journal-title":"Thyroid. Off. J. Am. Thyroid. Assoc."},{"key":"10.1016\/j.tranon.2026.103032_bib0042","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103032_bib0043","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Method."},{"key":"10.1016\/j.tranon.2026.103032_bib0044","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tranon.2026.103032_bib0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tranon.2026.103032_bib0046","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucl. Acid. Res."},{"key":"10.1016\/j.tranon.2026.103032_bib0047","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41467-024-45340-w","article-title":"UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103032_bib0048","first-page":"189","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science (1979)"},{"key":"10.1016\/j.tranon.2026.103032_bib0049","first-page":"1952","article-title":"Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer","volume":"22","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.tranon.2026.103032_bib0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0051","article-title":"Distinct prognostic values of S100 mRNA expression in breast cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103032_bib0052","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s12282-025-01737-z","article-title":"KLF13 promotes breast cancer progression through the HTRA1 and the hedgehog signaling pathway","volume":"32","author":"Huang","year":"2025","journal-title":"Breast. Cancer. Tokyo Jpn."},{"key":"10.1016\/j.tranon.2026.103032_bib0053","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature13119","article-title":"XBP1 promotes triple-negative breast cancer by controlling the HIF1\u03b1 pathway","volume":"508","author":"Chen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103032_bib0054","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12944-022-01713-y","article-title":"The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics","volume":"21","author":"Li","year":"2022","journal-title":"Lipid. Health Dis."},{"key":"10.1016\/j.tranon.2026.103032_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.04907","article-title":"Potential novel role of UDP glucuronosyltransferases 2B11 and 2B28 in crosstalk between androgen and lipid signalling","volume":"34","author":"Mackenzie","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.tranon.2026.103032_bib0056","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/ijc.30680","article-title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer","volume":"140","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2026.103032_bib0057","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-012-2340-x","article-title":"SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer","volume":"137","author":"de Ronde","year":"2013","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2026.103032_bib0058","article-title":"Targeting metabolic reprogramming in tumor: from mechanisms to precision immunotherapies","volume":"4","author":"Zhang","year":"2025","journal-title":"MedComm. \u2013 Oncol."},{"key":"10.1016\/j.tranon.2026.103032_bib0059","article-title":"Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2-positive breast cancer based on bioinformatics analysis and machine learning","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103032_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010008","article-title":"Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma","volume":"12","author":"Zhang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tranon.2026.103032_bib0061","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.csbj.2022.03.019","article-title":"Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer","volume":"20","author":"Thalor","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tranon.2026.103032_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tranon.2026.103032_bib0063","first-page":"94","article-title":"Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.tranon.2026.103032_bib0064","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s12276-024-01163-9","article-title":"Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tranon.2026.103032_bib0065","first-page":"132","article-title":"CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R\/STAT3 signaling","volume":"39","author":"Zhong","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.tranon.2026.103032_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217772","article-title":"Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies","volume":"625","author":"Bai","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103032_bib0067","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0068","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.tranon.2026.103032_bib0069","article-title":"Extensive infiltration of CD8+ T cells and M1 macrophages is beneficial for multiple cancer patients undergoing chemotherapy","volume":"3","author":"Bai","year":"2024","journal-title":"MedComm. \u2013 Oncol."},{"key":"10.1016\/j.tranon.2026.103032_bib0070","first-page":"51","article-title":"Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma","volume":"42","author":"Sui","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.tranon.2026.103032_bib0071","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tranon.2026.103032_bib0072","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-19-2925","article-title":"Siglec-15 as an emerging target for next-generation cancer immunotherapy","volume":"27","author":"Sun","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103032_bib0073","first-page":"3174","article-title":"Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters","volume":"65","author":"Quirino","year":"2021","journal-title":"Eur. J. Histochem. EJH"},{"key":"10.1016\/j.tranon.2026.103032_bib0074","article-title":"Integrin \u03b28 facilitates macrophage infiltration and polarization by regulating CCL5 to promote LUAD progression","volume":"12","author":"Song","year":"2025","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.tranon.2026.103032_bib0075","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2589658","article-title":"CD44v5 enhances the IL-4\/IL-4R\u03b1\/STAT6\/SAM68 aix inducing M2 polarization and promoting triple-negative breast cancer progression","volume":"26","author":"Ji","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2026.103032_bib0076","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/cas.16200","article-title":"CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R\/STAT3 axis","volume":"115","author":"Dai","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0077","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12929-017-0347-7","article-title":"Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions","volume":"24","author":"Hsieh","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tranon.2026.103032_bib0078","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/25387","article-title":"Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer","volume":"396","author":"Pitti","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103032_bib0079","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1074\/jbc.274.20.13733","article-title":"A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis","volume":"274","author":"Yu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2026.103032_bib0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2026.103032_bib0081","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts-the good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2026.103032_bib0082","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2025.10.026","article-title":"An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC","volume":"84","author":"Zhang","year":"2026","journal-title":"J. Hepatol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:31:27Z","timestamp":1791703887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":82,"alternative-id":["S1936523326003682"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103032","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siglec\u201315 promotes a feed-forward loop between TNBC cells and macrophages via the NF-\u03baB\/DcR3\/CCL18\/STAT3 axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103032"}}